FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
Loading...

Glenmark Life Sciences IPO

IPO Status: Listed [27th Jul 2021 to 29th Jul 2021]

Rated 4/5 by Team InvestorGain
Glenmark Life Sciences IPO Detail

Glenmark Lifesciences Limited, a leading Active Pharmaceutical Ingredients (API) manufacturer IPO of ₹ 1513.60 Cr opens on 27 July and closes on 29 July. The face value per share is Rs. 2, and the price band is fixed at Rs. 695-720. The floor price is 347.50 times and cap price is 360 times the face value. The lot size of the IPO is 20 shares. Stay tuned with us to know the opening and closing dates, price band, IPO lot size, and more.

Glenmark Life Sciences IPO Details

IPO Issue Opening Date: 27th Jul 2021
IPO Issue Closing Date: 29th Jul 2021
IPO Issue Price: ₹695-720 Per Share
DRHP: Download DRHP
RHP: Download RHP
Anchor List: Download Anchor List
IPO Listing At: BSE, NSE
Retail Quota: 50.23
IPO Issue Type: Book Build Issue
IPO Issue Size: ₹1513.60 Cr
Offer for Sale: ₹453.60 Cr
Fresh Issue: ₹1060 Cr.
Face Value: ₹2 Per Equity Share
IPO Discount: NA
Promoter Holding Pre IPO: 100%
Promoter Holding Post IPO: 82.84%
Allotment Status: Allotment Status
BSE Code: 543322
NSE Code: GLS

Glenmark Life Sciences IPO Important Dates

Get important updates regarding Glenmark Life Sciences IPO tentative timeline covering IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.

Glenmark Life Sciences IPO dates
IPO Activity Date
Basis of Allotment Date* 3rd Aug 2021
Refunds Initiation* 4th Aug 2021
Credit of Shares to Demat* 5th Aug 2021
IPO Listing Date* 6th Aug 2021

* - Tentative Dates

Glenmark Life Sciences IPO Lots

IPO Activity Date
Issue Price ₹695-720
Market Lot: 20 Shares
1 Lot Amount: ₹14400
Min Small HNI Lots(2-10 Lakh): 280 shares(14 lots)
Min Big HNI Lots(10+ Lakh):

Glenmark Life Sciences IPO GMP**

GMP DateIPO PriceGMPSub2 Sauda RateExpected Listing GainLast Updated
06-08-202172082--₹802 (11.39%)6-Aug-2021 10:35
IPO Live GMP
  1. The Pioneer Discount Broker
  2. Get 100% Free Delivery Trading
  3. Free Direct Mutual Funds & SIP

**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.

About Company - Glenmark Life Sciences

Glenmark Life Sciences Limited has established strong footprint in Active Pharmaceutical Ingredients manufacturing. The company manufactures high-quality APIS for different diseases like cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and others. It operates in business verticals; Generic APIs (Generic and Complex) and CDMO (Contract Development and Manufacturing operations) to serve specialty pharmaceutical companies.

Glenmark sells its products in India as well as other countries like Europe, Japan, Latin America, North America, etc. It has 4 manufacturing plants; 2 are in Gujarat and 2 are in Maharashtra. As of December 31, 2020, the manufacturing facilities have an aggregate installed capacity of 728.8 KL.

Glenmark Life Sciences IPO Strengths

  • Leading player in high-value, non-commoditized APIs in Chronic therapeutic areas.
  • Quality-focused manufacturing with R&D infrastructure.
  • Experienced management with a proven track record.
  • International market presence.
Incorporation Sector IPO Issue Size Website
2011 Pharmaceutical ₹1513.60 Cr http://www.glenmarklifesciences.com/

Glenmark Life Sciences IPO Objective

  • To pay purchase consideration to promoter for spin-off the API business from promoter to Glenmark Life Sciences Limited.
  • Finance capital expenditure requirements.
  • Meet general corporate purpose.
Request call back from Zerodha

Glenmark Life Sciences IPO Live Subscription (NSE + BSE)

The table below is live update of IPO bidding details from NSE and BSE.

  • Qualified Institutional Buyers: 4,242,379 Shares
  • Non-Institutional Investors: 3,232,770 Shares
  • Retail Individual Investor: 7,543,130 Shares
IPO Bidding Live Updates from BSE + NSE
Day QIBNIIRIITotal
 # of Shares Offered4,242,379 (28.25%)3,232,770 (21.53%)7,543,130 (50.23%)15,018,279
127th Jul 2021 17:020.00x0.86x5.17x2.78x
228th Jul 2021 17:031.38x3.39x9.28x5.78x
329th Jul 2021 17:0336.97x122.54x14.63x44.17x
Glenmark Life Sciences financial
Glenmark Life Sciences Limited Financials 31-Mar-2021 31-Mar-2020 31-Mar-2019
Total Assets ₹1,997.08 Cr ₹1,725.60 Cr ₹1,475.40 Cr
Total Income ₹1,885.98 Cr ₹1,549.30 Cr ₹886.87 Cr
Net Profit/Loss ₹351.58 Cr ₹313.10 Cr ₹195.59 Cr

Company Address

Glenmark Life Sciences Limited
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur,Maharashtra- 413 213
India
Website: http://www.glenmarklifesciences.com/
Phone: +91 2189 234456/ +91 2189
Email: [email protected]

Glenmark Life Sciences IPO Registrar

Kfin Technologies Limited
KFintech, Tower-B, Plot No 31 & 32,
Financial District, Nanakramguda, Gachibowli,
Hyderabad, Telangana India - 500 032.
Website: https://kosmic.kfintech.com/ipostatus/
Phone: 04067162222, 04079611000
Email: [email protected]
Glenmark Life Sciences IPO Important dates - Issue Open Date, close Date, IPO Listing Date. IPO Details - Offer Size, Issue Size, Type of IPO, Issue Price, Market Lot, BSE Cd, NSE Cd, IPO Listing date. What is the issue open date and close date for Glenmark Life Sciences? Should I apply in Glenmark Life Sciences IPO?

Last Updated on 27-Sep-2021 10:41:33


User Reviews

7. Rajesh Jul 28 2021 11:41:50 AM Reply
Kotak bank and Union Bank se ASBA k through kitni application apply kar sakte hain..
7.1. CA Sachin Jain Jul 28 2021 11:43:08 AM
Kotak and Union Bank ASBA IPO Application - 1 from Each Bank Account.
Only SBI, Axis, PNB allow up to 5 application from one bank account.
6. Vignesh A Jul 21 2021 08:25:20 AM Reply
GMP 220
5. Shubham Yashwant kale Jul 03 2021 10:56:06 PM Reply
Glenmark Life Sciences IPO expected listing gain.
4. Chebrolu Venkata Ramarao Jul 03 2021 10:56:06 PM Reply
Please confirm Glenmark Life Sciences IPO GMP (grey market premium) and kostak.
3. Vijay kumar chavan Jul 03 2021 10:56:06 PM Reply
Glenmark Life Sciences IPO good or bad.
2. Chinnathambi Jul 03 2021 10:56:06 PM Reply
Glenmark Life Sciences IPO whether to invest or not.
1. Mhd Anshar Jul 03 2021 10:56:06 PM Reply
Glenmark Life Sciences IPO - CRISIL Rating, Apply or not?.